We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,150 hedge funds and large institutions have $289B invested in Johnson & Johnson in 2025 Q1 according to their latest regulatory filings, with 253 funds opening new positions, 1,703 increasing their positions, 1,841 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $4.67B | Put options by funds: $2.57B

71% more first-time investments, than exits

New positions opened: 253 | Existing positions closed: 148

55% more funds holding in top 10

Funds holding in top 10: 146226 (+80)

12% more capital invested

Capital invested by funds: $257B → $289B (+$31.9B)

1% more funds holding

Funds holding: 4,1084,150 (+42)

0.4% more ownership

Funds ownership: 72.03%72.43% (+0.4%)

7% less repeat investments, than reductions

Existing positions increased: 1,703 | Existing positions reduced: 1,841

Holders
4,150
Holders Change
+42
Holders Change %
+1.02%
% of All Funds
55.62%
Holding in Top 10
226
Holding in Top 10 Change
+80
Holding in Top 10 Change %
+54.79%
% of All Funds
3.03%
New
253
Increased
1,703
Reduced
1,841
Closed
148
Calls
$4.67B
Puts
$2.57B
Net Calls
+$2.09B
Net Calls Change
+$1.56B
Name Holding Trade Value Shares
Change
Change in
Stake
LNB
1001
Ledyard National Bank
$8.26M -$347K -2,219 -4%
BCM
1002
Buckhead Capital Management
Georgia
$8.24M +$148K +945 +2%
NC
1003
Nicholas Company
Wisconsin
$8.22M -$3.13K -20 -0%
VSQM
1004
V-Square Quantitative Management
Illinois
$8.17M +$308K +1,966 +4%
OPTFSNA
1005
Old Point Trust & Financial Services N A
Virginia
$8.17M -$32.1K -205 -0.4%
ATPW
1006
Ashton Thomas Private Wealth
Arizona
$8.17M -$221K -1,412 -3%
CCG
1007
Chatham Capital Group
Georgia
$8.16M -$242K -1,548 -3%
HAIM
1008
Hunter Associates Investment Management
Pennsylvania
$8.15M -$88.6K -566 -1%
AFG
1009
Atomi Financial Group
New York
$8.14M +$1.38M +8,832 +22%
LWANC
1010
Laurel Wealth Advisors (North Carolina)
North Carolina
$8.13M -$85.1K -544 -1%
CAC
1011
Core Alternative Capital
Georgia
$8.12M -$1.37M -8,773 -15%
LI
1012
LMCG Investments
Massachusetts
$8.1M +$3.93M +25,087 +106%
FFA
1013
First Foundation Advisors
California
$8.09M +$267K +1,705 +4%
DAS
1014
Dynamic Advisor Solutions
Arizona
$8.07M +$346K +2,210 +5%
AM
1015
Atwater Malick
Pennsylvania
$8.07M +$152K +973 +2%
AMI
1016
Amica Mutual Insurance
Rhode Island
$8.06M -$2.7M -17,272 -26%
WW
1017
Windle Wealth
Oklahoma
$8.05M +$449K +2,868 +6%
DAS
1018
Diversify Advisory Services
Utah
$8.04M -$294K -1,881 -4%
FA
1019
Financial Avengers
California
$8.04M +$602K +3,848 +9%
TCM
1020
Telos Capital Management
California
$8.04M -$913K -5,837 -11%
Loomis, Sayles & Company
1021
Loomis, Sayles & Company
Massachusetts
$8.03M -$5.19M -33,172 -41%
AAMA
1022
Advanced Asset Management Advisors
Ohio
$8.03M -$782 -5 -0%
FM
1023
Foster & Motley
Ohio
$8.02M +$250K +1,598 +3%
IWM
1024
IHT Wealth Management
Illinois
$7.98M +$205K +1,309 +3%
AP
1025
Appleton Partners
Massachusetts
$7.97M -$293K -1,872 -4%

JNJ Hedge Fund Activity: Q1 2025 in Review

4,150 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2025, worth a combined $289B — up 12% from $257B a quarter earlier.

Buyers outnumbered sellers: 253 funds opened new JNJ positions and 148 closed out — a net gain of 105 holders — while 1,703 added to existing stakes and 1,841 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.39B. The largest seller was T. Rowe Price Associates, cutting an estimated $967M.

  • 4,150 institutional investors held Johnson & Johnson (JNJ) as of Q1 2025, up from 4,108 in Q4 2024.
  • Funds reported $289B of Johnson & Johnson stock for Q1 2025, up 12% quarter-over-quarter.
  • 253 funds opened new Johnson & Johnson positions in Q1 2025 and 148 closed out, a net change of +105 holders.
  • The largest Johnson & Johnson buyer in Q1 2025 was JP Morgan Chase, an estimated $2.39B added.
  • The largest Johnson & Johnson seller in Q1 2025 was T. Rowe Price Associates, an estimated $967M sold.

Based on aggregated 13F filings for Q1 2025.